Genentech Inc:企業の戦略的SWOT分析

◆英語タイトル:Genentech Inc - Strategic SWOT Analysis Review
◆商品コード:DATA904C15787
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Genentech Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Genentech Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that discovers, develops, manufactures and commercializes medicines to address serious medical needs. It offers drugs in various therapeutic areas including bio-oncology, immunology, ophthalmology, metabolism, primary care, neurology, virology, hematology and specialty care. Its pipeline products include Emicizumab (RG6013, ACE910), a bispecific monoclonal antibody used to replace the function of protein in the blood clotting process; and other products. The company has partnership with BioLineRx, Charles River Laboratories International and Amunix, among others. Genentech is headquartered in South San Francisco, California, the US.

Genentech Inc Key Recent Developments

Mar 11,2019 Susan G. Komen Announces New Funding Opportunity Focused on Better Understanding of Breast Cancer Disparities
Feb 11,2019 Samsung Bioepis forms new alliance to expand in China
Feb 06,2019 Xencor and Genentech partner on novel IL-15 cytokine drugs
Jan 24,2019 Genentech announces Alexander Hardy as Chief Executive Officer
Jan 17,2019 PhRMA welcomes Genentech and Gilead Sciences to association

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Genentech Inc – Key Facts
Genentech Inc – Key Employees
Genentech Inc – Key Employee Biographies
Genentech Inc – Major Products and Services
Genentech Inc – History
Genentech Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Genentech Inc – Business Description
Genentech Inc – SWOT Analysis
SWOT Analysis – Overview
Genentech Inc – Strengths
Genentech Inc – Weaknesses
Genentech Inc – Opportunities
Genentech Inc – Threats
Genentech Inc – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Genentech Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Mar 11, 2019: Susan G. Komen Announces New Funding Opportunity Focused on Better Understanding of Breast Cancer Disparities
Feb 11, 2019: Samsung Bioepis forms new alliance to expand in China
Feb 06, 2019: Xencor and Genentech partner on novel IL-15 cytokine drugs
Jan 24, 2019: Genentech announces Alexander Hardy as Chief Executive Officer
Jan 17, 2019: PhRMA welcomes Genentech and Gilead Sciences to association
Jan 09, 2019: NIIMBL Announces New Projects to Advance Biopharmaceutical Manufacturing
Nov 28, 2018: Roche subsidiary Genentech to acquire Jecure Therapeutics
Oct 04, 2018: Positive Phase III Results for Baloxavir Marboxil in People at High Risk of Complications From Influenza to be Presented at IDWeek 2018
Sep 13, 2018: FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA), a Rare Form of Juvenile Arthritis[Newswire : Healthcare-BW]
Jul 19, 2018: Genentech to present new data demonstrating the breadth and depth of its alzheimer’s program at the upcoming Alzheimer’s Association International Conference (AAIC)
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Genentech Inc, Key Facts
Genentech Inc, Key Employees
Genentech Inc, Key Employee Biographies
Genentech Inc, Major Products and Services
Genentech Inc, History
Genentech Inc, Other Locations
Genentech Inc, Key Competitors
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Genentech Inc, Recent Deals Summary

List of Figures
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Genentech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Genentech Inc:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BT Global Services Limited:企業の戦略的SWOT分析
    BT Global Services Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Direct Energy Marketing Ltd:企業の戦略的SWOT分析
    Direct Energy Marketing Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Roche Diagnostics International Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Roche Diagnostics International Ltd (Roche Diagnostics), a subsidiary of F. Hoffmann-La Roche Ltd, is a provider of diagnostic system solutions to clinics, laboratories and doctors’ offices. The company develops, produces and services instruments and software systems used in in vitro diagnos …
  • Euronet Worldwide Inc (EEFT):企業の財務・戦略的SWOT分析
    Euronet Worldwide Inc (EEFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Hang Seng Bank Ltd:企業の戦略・SWOT・財務情報
    Hang Seng Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Hang Seng Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • EnCana Corp (ECA):企業の財務・戦略的SWOT分析
    EnCana Corp (ECA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • International Business Machines Corporation:企業のM&A・事業提携・投資動向
    International Business Machines Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's International Business Machines Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • Exide Technologies:企業の戦略・SWOT・財務分析
    Exide Technologies - Strategy, SWOT and Corporate Finance Report Summary Exide Technologies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nigeria LNG Ltd:企業の戦略的SWOT分析
    Nigeria LNG Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • National Taiwan University Hospital-製薬・医療分野:企業M&A・提携分析
    Summary National Taiwan University Hospital (NTUH) is a healthcare service provider that offers biomedical, clinical research and patient care services. The hospital’s research activities include community-based intervention programs, multicenter controlled clinical trials, program projects, researc …
  • Xylem Inc (XYL)-エネルギー分野:企業M&A・提携分析
    Summary Xylem Inc. (Xylem) is a water technology company that designs, manufactures, and service engineered technologies for water industry. The company’s products portfolio includes testing equipment; filtration, disinfection and biological treatment equipment; controls and systems; and water and w …
  • Tenet Healthcare Corp (THC)-製薬・医療分野:企業M&A・提携分析
    Summary Tenet Healthcare Corp (Tenet) is a health care services company that operates hospitals, diagnostic imaging centers, ambulatory surgery centers, and related health care facilities along with its subsidiaries and affiliates. It is one of the leading healthcare services companies in the US, wi …
  • BOC Aviation Limited (2588):企業の財務・戦略的SWOT分析
    BOC Aviation Limited (2588) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Quanta Services Inc (PWR)-石油・ガス分野:企業M&A・提携分析
    Summary Quanta Services, Inc. (Quanta) is a specialized contracting services company that offers infrastructure solutions. It designs, installs, upgrades, repairs and maintains infrastructure of electric power transmission and distribution networks, substation facilities, renewable energy facilities …
  • ABB, Ltd.:企業の戦略・SWOT・財務情報
    ABB, Ltd. - Strategy, SWOT and Corporate Finance Report Summary ABB, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Sysmex Inostics GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Sysmex Inostics GmbH (Sysmex Inostics), formerly Inostics GmbH, a subsidiary of Sysmex Corp, is a molecular diagnostics company that offers blood-based cell-free tumor treatment solutions. The company offers services such as clinical trials, research and development, and testing for physicia …
  • MetLife, Inc.:企業の戦略・SWOT・財務情報
    MetLife, Inc. - Strategy, SWOT and Corporate Finance Report Summary MetLife, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • ImaginAb Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ImaginAb Inc (ImaginAb) is an immune and oncology imaging company that develops in vivo antibody-based imaging agents. It is engaged in the discovery, development, and production of new compounds and products in human health and cosmetics, agriculture and food sectors. The company’s product …
  • Hon Hai Precision Industry Co Ltd (2317):企業の財務・戦略的SWOT分析
    Hon Hai Precision Industry Co Ltd (2317) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Optimum General Inc.
    Optimum General Inc. - Strategy, SWOT and Corporate Finance Report Summary Optimum General Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆